- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07261761
Cytokines as Diagnostic Markers of Pulpal Inflammation and Their Impact on the Outcome of Vital Pulp Therapy (Pulp Therapy)
November 28, 2025 updated by: Mohamed Khalifa, Mansoura University
intervention eligible patients with teeth diagnosed with reversible or irreversible pulpits will go for vital pulp therapy and the other group will be patients will go for extraction of caries free teeth for orthodontic reasons, blood samples will be collected from both groups to analyze the level of cytokines IL-8 and IL-10 and it's relation with the success of the pulp therapy
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Al Mansurah, Egypt
- Faculty of Dentistry, Mansoura Univeristy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- The age ranges from 16-45 years medically free.
- Tooth should be vital on cold testing.
- Vital permanent premolar and molar on cold testing, with deep caries, subsequent pulp exposure and bleeding pulp tissue in all canals after complete pulpotomy.
- Diagnosis is either reversible or irreversible pulpitis with/ without periapical rarefaction.
- The tooth is restorable and free from advanced periodontal disease.
- Soft tissues around the tooth are normal with no swelling or sinus tract.
Exclusion Criteria:
- Patients over 45 years of age.
- Patients with clinical symptoms of periradicular inflammation or any periradicular radiographic lesions.
- Negative results for cold and electrical pulp testing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Molars or premolars with Reversible or irreversible pulpits
fifteen patients with carious teeth showing signs and symptoms of pulp inflammation
|
after access opening blood sample will be collected
|
|
Active Comparator: Caries free molars or premolars
fifteen patients with intact human premolars planed for extraction for orthodontic reason
|
after access opening blood sample will be collected
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical success
Time Frame: one day, one, four and twelve weeks.
|
post operative pain on cold testing binary outcome (Yes or no)
|
one day, one, four and twelve weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiographic success
Time Frame: Pre-operative , and after six months
|
Cone Beam Computed Tomography CBCT radiographic Examination for any periodontal widening or any periapical radiolucency.
|
Pre-operative , and after six months
|
|
level of cytokines
Time Frame: through study completion, an average of 6 months
|
level of Interleukin 8 and Interleukin 10 will be measured using Enzyme- Linked Immunosorbent assay (ELISA) Kit
|
through study completion, an average of 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2022
Primary Completion (Actual)
October 1, 2024
Study Completion (Actual)
April 2, 2025
Study Registration Dates
First Submitted
November 19, 2025
First Submitted That Met QC Criteria
November 28, 2025
First Posted (Estimated)
December 3, 2025
Study Record Updates
Last Update Posted (Estimated)
December 3, 2025
Last Update Submitted That Met QC Criteria
November 28, 2025
Last Verified
July 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- M05060722
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Irreversible Pulpitis
-
Tehran University of Medical SciencesActive, not recruitingSymptomatic Irreversible Pulpitis (SIP) | Symptomatic Irreversible Pulpitis With Apical PeridontitisIran
-
Cairo UniversityNot yet recruitingPulpitis - Reversible | Pulpitis - Irreversible
-
Urooj FatimaNot yet recruitingSymptomatic Irreversible Pulpitis | Irreversible Pulpitis | Asymptomatic Irreversible PulpitisPakistan
-
Inonu UniversityRecruitingPulpitis - Reversible | Pulpitis - IrreversibleTurkey (Türkiye)
-
Cukurova UniversityCompletedPulpitis - IrreversibleTurkey (Türkiye)
-
Jamia Millia IslamiaRecruiting
-
Cairo UniversityNot yet recruiting
-
Minia UniversityNot yet recruiting
-
Chulalongkorn UniversityNot yet recruiting
-
Sirawut Hiran-usChulalongkorn UniversityActive, not recruiting
Clinical Trials on Vital pulp therapy
-
Minia UniversityRecruiting
-
Ain Shams UniversityRecruiting
-
British University In EgyptRecruitingPulpitis - IrreversibleEgypt
-
Future University in EgyptRecruitingIrreversible PulpitisEgypt
-
Postgraduate Institute of Dental Sciences RohtakCompletedReversible Pulpitis
-
Minia UniversityNot yet recruiting
-
Ain Shams UniversityActive, not recruitingSymptomatic Irreversible PulpitisEgypt
-
Cairo UniversityNot yet recruitingPulp Disease, Dental | Knowledge
-
Al-Azhar UniversityActive, not recruitingVital Pulp Therapy in Young Permanent ToothEgypt
-
Future University in EgyptRecruiting